* Jaguar Health Inc JAGX.OQ reported a quarterly adjusted
loss
of 69 cents per share for the quarter ended in June. The lone
analyst forecast for the quarter was for a loss of $1.53 per
share.
* Revenue fell 8.4% to $2.68 million from a year ago;
analysts
expected $2.28 million.
* Jaguar Health Inc's reported EPS for the quarter was a
loss
of 69 cents.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Jaguar Health Inc shares had risen by 10.8% this
quarter and
lost 91.2% so far this year.
* The company reported a quarterly loss of $12.15 million.
* Wall Street's median 12-month price target for Jaguar
Health Inc
is $6.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 1 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 14 at 02:58 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -1.53 -0.69 Beat
Sep. 30 2022 -5.62 -9.00 Missed